These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15870887

  • 1. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.
    Huygens A, Kamuhabwa AR, Van Laethem A, Roskams T, Van Cleynenbreugel B, Van Poppel H, Agostinis P, De Witte PA.
    Int J Oncol; 2005 Jun; 26(6):1691-7. PubMed ID: 15870887
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
    Kamuhabwa A, Agostinis P, Ahmed B, Landuyt W, van Cleynenbreugel B, van Poppel H, de Witte P.
    Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
    [Abstract] [Full Text] [Related]

  • 7. Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells.
    Huygens A, Kamuhabwa AR, Roskams T, VAN Cleynenbreugel B, VAN Poppel H, de Witte PA.
    J Urol; 2005 Jul; 174(1):69-72. PubMed ID: 15947580
    [Abstract] [Full Text] [Related]

  • 8. Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids.
    Roelants M, Van Cleynenbreugel B, Lerut E, Van Poppel H, de Witte PA.
    Photochem Photobiol Sci; 2011 Jan; 10(1):151-9. PubMed ID: 21103512
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin.
    Kamuhabwa AA, Roskams T, D'Hallewin MA, Baert L, Van Poppel H, de Witte PA.
    Int J Cancer; 2003 Nov 10; 107(3):460-7. PubMed ID: 14506748
    [Abstract] [Full Text] [Related]

  • 11. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY, Bay BH, Olivo M.
    Int J Oncol; 2003 May 10; 22(5):1019-24. PubMed ID: 12684667
    [Abstract] [Full Text] [Related]

  • 12. Hypericin-mediated photocytotoxic effect on HT-29 adenocarcinoma cells is reduced by light fractionation with longer dark pause between two unequal light doses.
    Sacková V, Kuliková L, Mikes J, Kleban J, Fedorocko P.
    Photochem Photobiol; 2005 May 10; 81(6):1411-6. PubMed ID: 16354114
    [Abstract] [Full Text] [Related]

  • 13. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
    Chen B, Roskams T, de Witte PA.
    Lasers Surg Med; 2002 May 10; 31(3):158-63. PubMed ID: 12224088
    [Abstract] [Full Text] [Related]

  • 14. Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin.
    Huygens A, Crnolatac I, Develter J, Van Cleynenbreugel B, Van der Kwast T, de Witte PA.
    J Urol; 2008 May 10; 179(5):2014-9. PubMed ID: 18355860
    [Abstract] [Full Text] [Related]

  • 15. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
    Seitz G, Krause R, Fuchs J, Heitmann H, Armeanu S, Ruck P, Warmann SW.
    Oncol Rep; 2008 Nov 10; 20(5):1277-82. PubMed ID: 18949433
    [Abstract] [Full Text] [Related]

  • 16. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
    Wang X, Guo Y, Yang S, Wang C, Fu X, Wang J, Mao Y, Zhang J, Li Y.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):847-53. PubMed ID: 20551295
    [Abstract] [Full Text] [Related]

  • 17. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2007 Oct 01; 20(4):421-8. PubMed ID: 17786271
    [Abstract] [Full Text] [Related]

  • 18. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS, Watt F, Ren MQ, Tan PH, Soo KC, Olivo M.
    J Photochem Photobiol B; 2006 Jan 02; 82(1):1-8. PubMed ID: 16203156
    [Abstract] [Full Text] [Related]

  • 19. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B, Zupkó I, de Witte PA.
    Int J Oncol; 2001 Apr 02; 18(4):737-42. PubMed ID: 11251168
    [Abstract] [Full Text] [Related]

  • 20. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
    Du HY, Olivo M, Tan BK, Bay BH.
    Int J Oncol; 2003 Nov 02; 23(5):1401-5. PubMed ID: 14532982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.